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Aim: The epithelial layer within the colon represents a physical barrier between the luminal contents 
and its underlying mucosa. It plays a pivotal role in mucosal homeostasis, and both tolerance and 
anti-pathogenic immune responses. Identifying signals of inflammation initiation and responses to 
stimuli from within the epithelial layer is critical to understanding the molecular pathways underly-
ing disease pathology. This study validated a method to isolate and analyze epithelial populations, 
enabling investigations of epithelial function and response in a variety of disease setting. 
Materials and methods: Epithelial cells were isolated from whole mucosal biopsies harvested 
from healthy controls and patients with active ulcerative colitis by calcium chelation. The purity 
of isolated cells was assessed by flow cytometry. The expression profiles of a panel of epithelial 
functional genes were investigated by reverse transcription-polymerase chain reaction (PCR) in 
isolated epithelial cells and corresponding mucosal biopsies. The expression profiles of isolated 
cells and corresponding mucosal biopsies were evaluated and compared between healthy and 
inflamed colonic tissue. 
Results: Flow cytometry identified 97% of cells isolated as intestinal epithelial cells (IECs). 
Comparisons of gene expression profiles between the mucosal biopsies and isolated IECs 
demonstrated clear differences in the gene expression signatures. Sixty percent of the examined 
genes showed contrasting trends of expression between sample types.
Conclusion: The calcium chelation isolation method provided a reliable method for the isolation 
of a pure population of cells with preservation of epithelial cell-specific gene expression. This 
demonstrates the importance of sample choice when investigating functions directly affecting 
the colonic epithelial layer.
Keywords: epithelial cells, ulcerative colitis, gene expression, mucosal biopsies, molecular 
pathways, colonic inflammation
Introduction
Epithelial surfaces, including the skin, respiratory, urinary, and gastrointestinal tracts, 
provide a physical and immunological barrier between the host and the external envi-
ronment.1 Within the colon, a single layer of intestinal epithelial cells (IECs) separates 
the colonic microbiome, estimated at 1014 bacterial cells,2 and other external antigens 
from the underlying lamina propria (LP).1 IECs also participate in co-ordination of 
appropriate immune responses, including tolerance and anti-pathogen responses.1 
Gene expression analysis of colonic mucosa from animals,3–6 patients with inflam-
matory bowel disease7–9 and other conditions associated with impaired IEC barrier 
function, such as graft-versus-host disease, autism, type 1 diabetes, rheumatoid arthritis, 
and multiple sclerosis,10–15 has provided insights into the molecular pathways of IEC 
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function. However, mucosal biopsies may not be appropriate 
to investigate gene expression changes in IECs due to the het-
erogenic nature of tissues in mucosal biopsies.16–19 Thus, gene 
expression in IECs may be obscured by gene expression of 
other cell types,20,21 masking subtle gene expression changes.22
Fluorescence-activated cell sorting (FACS) is widely used 
for high throughput cell sorting, allowing simultaneous mea-
surement of over 20 parameters per cell 23 at a rate of 1,000 
cells per second.24–26 An alternative method for cell sorting is 
laser capture microdissection, which can be used to isolate 
IECs;27 however, ultraviolet and infrared laser energy can 
damage isolated cells28 and stereology of the sample is lost.29
The primary aim of this study was to develop a technique 
to isolate IECs from mucosal biopsies obtained from patients 
with ulcerative colitis (UC) and healthy volunteers in order 
to successfully study gene expression in cells that provide 
the primary interface between the host and the colonic 
microbiota. In doing so, IECs must be isolated in sufficient 
volume and integrity that preserves both gene expression 
signature and RNA quality. Here, we describe adoption of 
a method (calcium chelation) routinely used to isolate IECs 
for cell culture, to yield high-quality RNA for the purpose 
of gene expression studies. 
Materials and methods
Patient volunteers
Volunteers were recruited from St. Vincent’s University 
Hospital (SVUH), Dublin, Ireland, in accordance with ethical 
approval granted by SVUH, Ethics Committee, and Medi-
cal Research Committee. All individuals provided written 
informed consent prior to the procedure. All participants 
were greater than 18 years of age.
Two mucosal biopsy specimens were harvested from the 
descending colon in 10 healthy volunteers and 10 patients 
with active UC. Healthy volunteers underwent routine 
day-case colonoscopy and were found to have no active 
pathology. Volunteers with a history of inflammatory bowel 
disease, colon cancer, active gastrointestinal bleeding, or 
hospital admission in the preceding 6 weeks were excluded. 
All volunteers had received a bowel preparation of sodium 
picosulfate. Individuals with UC underwent total colectomy 
for medically refractory UC or acutely unresponsive disease. 
Phenotypic data and demographics were collected at the 
time of consent and following a review of medical notes 
(Table 1). No significant differences were observed between 
the two cohorts regarding sex or age (P>0.05).
sample collection and processing
Parallel mucosal biopsies were harvested from the descending 
colon of recruited individuals. For healthy individuals, biopsy 
samples were collected using a Radial Jaw® 3 biopsy forceps 
(Boston Scientific, Natick, MA, USA). For individuals with 
UC, biopsy samples were collected at the time of colonic 
resection. The colon was opened along the antimesenteric 
border and sampled immediately post-removal. Immediately 
following collection, two biopsy samples were placed in 
Table 1 Phenotypic data and demographics of study volunteers
Cohort Characteristics Subcategory Results (n)
healthy controls Gender Female 6
Male 4
age, years Mean 47
range 24–62
indication Screening for family history of bowel disease 2
surveillance post-polypectomy 2
rectocele 1
hemorrhoids 3
screening post-appendicitis 1
surveillance 1
acute ulcerative colitis Gender Female 4
Male 6
age, years Mean 48
range 18–83
Mayo score Mean 10
range 7–12
Treatment strategy steroids 7
aminosalicylate 7
anti-TnFα 7
Abbreviation: TNF, tumor necrosis factor.
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RNAlater® solution (Ambion, Austin, TX, USA) and stored 
at 4°C for 24 hours prior to storage at –80°C. One of the 
mucosal biopsy samples was used for epithelial cell isola-
tion and analysis. The second sample was used for whole 
mucosal analysis. 
Calcium chelation solution
EDTA (ethylenediaminetetraacetic acid) calcium chelation 
solution was prepared as described previously.30 Briefly, the 
solution contained the following: 96 mM/L NaCl, 1.5 mM/L 
KCl, 10 mM HEPES/Tris, 27 mM NaEDTA, 45 mM/L Sor-
bitol, and 28 mM/L sucrose. All reagents were sourced from 
Sigma-Aldrich Co. (St Louis, MO, USA). Prior to use, the 
solution was treated with 1X RNase secure (Ambion) for 10 
minutes at 65°C. 
Crypt isolation by calcium chelation 
protocol
Mucosal biopsies were washed three times in 1.5 mL of 
Dulbecco’s phosphate buffered solution (dPBS) (Thermo 
Fisher Scientific, Waltham, MA, USA), which was pretreated 
with 1X RNAse secure (Ambion) for 10 minutes. Biopsies 
were then transferred to a fresh, sterile microcentrifuge tube 
and incubated in 1.5 mL of calcium chelation solution, and 
shaken on ice for 1 hour with gentle agitation at 80 rpm. After 
incubation samples were shaken vigorously, the supernatant 
(containing the epithelial cells) was transferred to a fresh 
sterile microcentrifuge and centrifuged at 200× g for 10 
minutes to pellet the cells. The supernatant was discarded 
and the cell pellet was washed twice in 1.5 mL of dPBS and 
resuspended in dPBS. 
Following this, 50 μL of the cell suspension was aliquoted 
for the purpose of purity assessment through flow cytometry. 
The remainder of the sample was utilized for the purpose of 
RNA extraction.
Flow cytometry assessment of epithelial 
cell purity
The purity of isolated cells was assessed through flow 
cytometry in combination with antibody labeling specific 
for epithelial cells. Isolated cells were diluted 1:1 with 0.4% 
trypan blue stain (Thermo Fisher Scientific) counted using a 
Countess™ automated cell counter (Thermo Fisher Scien-
tific). Following this, samples were diluted to 106 cells/mL 
and blocked in 1% bovine serum albumin (Sigma-Aldrich 
Co.) prior to incubation for 1 hour at room temperature with 
Anti-Human CD326 (EpCAM) eFluor® 660 antibody con-
jugated with allophycocyanin (APC; eBioscience, Hatfield, 
UK) at a final concentration of 0.06 μg/mL. The labeled cells 
were analyzed using the BD Accuri™ C6 (Accuri Cytomer-
ers, Ann Arbor, MI, USA) and BD Accuri C6 software. 
Unlabeled cells that served as a negative control were used 
in gating analysis to establish single cell populations and to 
exclude nonepithelial cells. 
Extraction of total RNA and cDNA 
generation from isolated epithelial cells 
and whole mucosal biopsy
RNA was extracted from mucosal biopsies and the isolated 
IECs using the Qiagen RNeasy® Fibrous Tissue kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s method 
for tissue samples. 
Nucleic acid concentration and purity was determined by 
the NanoDrop ND-100- spectrophotometer (Thermo Fisher 
Scientific). The integrity of RNA from mucosal biopsies 
was evaluated using the Agilent 2100 Bioanalyzer (Agilent, 
Santa Clara, CA, USA) in conjunction with the RNA Nano 
6000 kit (Agilent). As the RNA yield from epithelial cells 
was below the limit of detection for the RNA Nano Kit, the 
remainder of the biopsy sample, representing the LP and had 
undergone crypt isolation by calcium chelation in conjunction 
with the epithelial cells, was used as a proxy to investigate 
the integrity of the epithelial cells.
Preamplification of RNA from isolated 
epithelial cells
Following RNA isolation, cDNA was generated using the 
High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA, USA) as per the manufacturer’s 
instructions. Given the low yield of RNA from the isolated 
IECs, the cDNA generated from these samples was preampli-
fied prior to gene expression analysis. This was carried out 
using the Roche Pre-Amp Mastermix and Pre-Amp Primer 
Pool (Hoffman-La Roche Ltd., Basel, Switzerland) as per 
the manufacturer’s instructions. Preamplification reactions 
consisted of an initial denaturation step for 1 minute at 95°C 
followed by 14 amplification cycles of 95°C for 15 seconds 
and 60°C for 4 minutes. Finally, samples were cooled to 37°C 
for 15 minutes. Each amplification reaction mixture was then 
diluted 1:40 with nuclease-free water (Hoffman-La Roche 
Ltd.) and stored at –20°C prior to gene expression analysis. 
Gene expression profiling 
Roche RTR Custom Panels (Hoffman-La Roche Ltd.) were 
employed to study the gene expression of 20 gene targets 
and three reference genes. Prior to performing reverse 
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transcription-PCR the Roche RTR Human Reference Gene 
Panel (Hoffman-La Roche Ltd.) was used to investigate 
the crossing point (Cp) values of 19 common reference 
genes in our two patient cohorts. Subsequently, RefFinder 
software31 (http://www.leonxie.com/referencegene.php) 
identified the most stable genes across the two cohorts. 
RefFinder considers the normalization calculations of 
geNorm,32 NormFinder,33 BestFinder,34 and delta Cp val-
ues.35 RefFinder predicted IPO8 as the most stable gene 
across the given sample tissues with Beta-globulin being 
the least. Furthermore, NormFinder predicted three as the 
ideal number of reference genes required for normalization. 
On this basis, IPO8, HPRT1, and GUSB were selected as 
the ideal reference genes for performing normalization in 
subsequent RT-PCR experimental designs. All assays were 
carried out on a LightCycler® 480 Instrument (Hoffman-La 
Roche Ltd.) as per the standard PCR cycling conditions. 
Data analysis was performed using LightCycler software 
4.1 (Hoffman-La Roche Ltd.). Cp values were derived 
using the second derivative algorithm and normalization. 
Cp value for each target was used to calculate the relative 
expression levels using the comparative Cp method.36 
Statistical significance was evaluated using the Mann–
Whitney U-test with a Bonferroni correction for multiple 
hypothesis testing. All statistical analysis was carried 
out using SPSS software version 20 (IBM Corporation, 
Armonk, NY, USA).
Results
Crypt isolation by calcium chelation
Flow cytometry was used to detect the binding of an antibody 
specific to epithelial cell adhesion molecule, on the surface of 
the isolated epithelial cell population. An aliquot of isolated 
cells from eight individuals was counted and stained with 
Anti-Human CD326 (EpCAM) eFluor 660 conjugated with 
APC. The labeled cells were analyzed using the BD Accuri 
C6. Gating was established using unlabeled cells that acted 
as a negative control ( Figure 1). It was determined that 97% 
(range: 77–99%) of cells were of epithelial origin (Figure 1, 
Table 2). Direct microscopical examination of the isolate 
culture also identified a pure population of epithelial cells 
(Figure 2).
The mean yields of RNA, its quality and purity of isolated 
IECs are presented in Table 2. Given the low yields of RNA 
Figure 1 Confirmation of epithelial cells isolated by calcium chelation technique. (A) Unstained cells acted as a negative control for the purpose of performing gating analysis 
and (B) 97% (median) of cells within the population were positive for EpCAM staining.
Abbreviation: FSC-A, forward scatter area.
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Table 2 Summary of RNA yields and quality checks from whole mucosal biopsies and isolated IECs
Sample type Mean quantity,  
ng/uL (range)
Mean purity,  
OD 260/280 (range)
Mean RIN value  
(range)
Purity of isolated  
IECs, % (range)
Mucosal biopsy 453 (180–656) 1.8 (1.6–2.2) 8.3 (7–9.3) n/a
isolated iECs 16 (4.6–39.6) 1.90 (1.5–2.1) n/a 97 (77–99)
lP and submucosa 393.5 (61–486) 2.13 (1.7–2.2) 5.7 (3.1–6.9) n/a
Abbreviations: iECs, intestinal epithelial cells; lP, lamina propria; OD, optical density; rin, rna integrity number; n/a, not applicable.
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Figure 2 Microscopical image of isolated epithelial cells (40× magnification).
Crypt base
Crypt apex
Table 3 ΔCp and relative fold change in gene expression for mucosal biopsy and isolated IECs
Gene name Associated  
function
Gene  
symbol
Relative gene expression (ΔCp) Fold change  
(HC vs UC)
Mucosal  
biopsy  
(healthy 
controls)
IECs  
(healthy 
controls)
Mucosal  
biopsy 
(ulcerative 
colitis)
IECs 
(ulcerative 
colitis)
Mucosal 
biopsy 
(2-ΔΔCp)
IECs
(2-ΔΔCp) 
BCl2-associated X protein apoptosis BAX –0.94 –1.90 –0.81 –0.16 –0.14 –1.72
Caspase 3, apoptosis-related 
cysteine peptidase
apoptosis CASP3 –0.39 –1.62 0.30 1.11 –0.68 –3.23
Caspase 7, apoptosis-related 
cysteine peptidase
apoptosis CASP7 1.16 –0.09 1.94 2.08 –0.77 –2.61
TNF superfamily, member 6 apoptosis FasL 2.87 –7.66 3.14 –3.55 –0.26 –4.11
Solute carrier family 16, member 1 Butyrate transport SLC16A1 –2.67 –1.44 –0.04 1.90 –2.63 –3.31
Defensin alpha 5 Bacterial defensin DEFA5 4.95 6.33 –2.71 9.82 7.66 –3.49
Defensin alpha 6 Bacterial defensin DEFA6 5.89 –7.29 –0.56 –3.13 6.46 –4.16
Defensin beta 1 lipopolysaccharide 
response
DEFB1 –1.28 –2.29 1.47 2.57 –2.74 –6.16
Deleted in malignant brain  
tumors 1
lipopolysaccharide 
response
DMBT1 –0.82 –2.45 –5.34 –3.51 4.52 1.54
lipocalin 2 lipopolysaccharide 
response
LCN2 1.17 –0.30 –5.04 –4.25 6.21 3.95
Matrix metallopeptidase 9 lipopolysaccharide 
response
MMP9 2.67 1.65 0.67 –0.58 2.00 2.65
regenerating islet-derived 3 alpha lipopolysaccharide 
response
REG3A 6.31 –7.74 –1.88 –4.28 8.19 –3.45
resistin like beta lipopolysaccharide 
response
RETNLB –3.14 –9.23 –1.22 –4.80 –4.43 –1.93
TIMP metallopeptidase inhibitor 1 lipopolysaccharide 
response
TIMP1 0.36 0.89 –3.03 0.46 3.39 0.49
Trefoil factor 1 lipopolysaccharide 
response
TFF1 –1.13 –7.34 –3.70 –5.28 2.56 –2.07
Trefoil factor 3 Mucus gel layer 
component
TFF3 –5.43 –5.81 –4.41 –2.12 –1.00 –3.69
Carbohydrate 
(N-acetylglucosamine 6-O) 
sulfotransferase 5
Mucus gel layer 
component
CHST5 –1.44 –1.61 0.01 –1.33 –1.43 –0.26
Mucin 2, oligomeric mucus/gel 
forming
Mucus gel layer 
component
MUC2 –6.80 –8.99 –6.93 –10.18 0.11 2.29
Toll-like receptor 2 response to microbial 
stimuli
TLR2 6.02 –6.61 3.89 –3.24 2.14 –3.36
Toll-like receptor 4 response to microbial 
stimuli
TLR4 0.59 –6.68 –0.03 –2.95 0.58 –3.73
Notes: Fold change expression which showed significant difference between UC and healthy controls is highlighted in bold. 
Abbreviations: IECs, intestinal epithelial cells; ΔCp, relative gene expression; HC, healthy controls; UC, ulcerative colitis; TNF, tumor necrosis factor.
from the isolated IECs, an assessment of the RNA integrity 
was not feasible. As a proxy for this measurement, a parallel 
extraction of RNA was performed from the remaining biopsy 
tissue (LP) from which the IECs were isolated. 
Transcriptional profiling of mucosal 
biopsies and isolated iECs
Relative gene expression (ΔCp) of both mucosal biopsies and 
isolated IECs in healthy and inflamed UC tissue are presented 
in Table 3, along with fold changes (2-ΔΔCp) of each tissue type 
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in UC compared to healthy controls (Figure 3). The panel 
of 20 genes investigated were selected with the purpose of 
investigating signatures from IEC-specific functions. 
Comparisons of gene expression (ΔCp) between the 
mucosal biopsies and isolated IECs demonstrated clear dif-
ferences in the gene expression signatures of each sample 
type. Twelve of the 20 genes examined showed contrasting 
trends of gene expression between sample types in one or 
both of the sample cohorts, indicating that the mixed tissues 
of the mucosal biopsies do not appropriately reflect the gene 
signatures of the epithelial cell environment. A comparison 
of the fold changes in gene expression between samples 
obtained from individuals with UC and that of healthy 
controls further highlighted this observation. Seven of the 
20 genes showed a dichotomy in the direction of expression 
between the sample types and importantly all but one of 
these genes were significantly altered between the cohorts. 
Also of importance was the observation that 6/20 of the 
genes were significantly altered in one of the sample types 
only. To further demonstrate the dissimilarity of the sample 
types (IEC vs mucosal biopsies), Pearson’s correlation coef-
ficients were calculated between the two sample types of each 
patient cohort (healthy controls [HC] and UC) and found no 
significant discernible correlation between the tissue types 
in either of the tested cohorts (Table 4).
Discussion
The technique described represents an adoption of a pre-
viously published method30 to isolate IECs, resulting in a 
robust and efficient method for preservation of IEC-specific 
gene expression signatures. The original technique has been 
extensively used for physiology studies of the epithelial layer, 
without any adverse effect on epithelial function reported.30,37 
Moreover; crypt isolation by calcium chelation has been used 
in studies investigating calcium-sensing receptor (CaSR). 
Exposure of isolated epithelial cells to CaSR activator R568 
(100 nM) resulted in a sustained increase of [Ca2+]i from 
100 nm to 350 nm,38–40 suggesting that intracellular calcium 
stimulation is not directly affected by the chelation technique. 
The technique along with the more expensive FACS tech-
nique has been used for the isolation of both organoids and 
enteroids for subsequent studies,41,42 to offer a better under-
standing of how stem cells differentiate and to study the role 
these cells may play in the biology of colonic diseases such 
as colorectal cancer.43 While these studies have offered the 
potential to explore interactions involved in pathogenesis, the 
techniques employed have not preserved the gene expression 
profiles that directly reflect in vivo circumstances and do not 
offer the potential to study these. 
Figure 3 log2 fold change (HC vs UC) in gene expression for mucosal biopsy (red) and isolated IECs (blue).
Abbreviations: iECs, intestinal epithelial cells; UC, ulcerative colitis; hC, healthy controls.
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Table 4 Pearson’s correlation coefficients between gene 
expression profiles of IEC versus mucosal biopsies
Relative gene expression (ΔCp)  
(IEC vs mucosal biopsies)
R2-value P-value
all samples
healthy
active UC
0.216
0.171
0.327
>0.05
>0.05
>0.05
Abbreviations: IECs, intestinal epithelial cells; ΔCp, relative gene expression; UC, 
ulcerative colitis.
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The adopted technique includes a reagent pretreatment 
step to remove contaminating RNAse enzymes and performs 
all isolation steps on ice, thus allowing for the integrity of the 
resulting RNA to be preserved and ensuring suitability for 
gene expression analysis. However, due to the small sample 
size yielded from the IEC isolation method, it was not feasible 
to check the RNA integrity of the extracts before proceeding 
to amplification and analysis. To overcome this, the mucosa 
that remained post-IEC isolation was also subjected to RNA 
extraction and was used as a proxy for the purpose of assess-
ment of RNA integrity. 
In this study, the RNA yielded from the EDTA calcium 
chelation method described earlier was isolated, from a single 
biopsy collected with a Radial Jaw 3 biopsy forceps that 
provided sufficient RNA to study 20 genes. Future studies 
could increase the number of gene targets investigated by 
increasing the number of biopsies harvested from a patient 
and pooling the IECs prior to RNA extraction or by using 
animal models whereby large amounts of the colon could be 
harvested for IEC extraction. 
IECs play an important role in colonic homeostasis and 
are considered to be deregulated in a number of colonic condi-
tions.1 The panel of genes chosen for gene expression analysis 
was based on known functions of epithelial cells including 
mucus gel layer (MGL) and defensin secretions, responses 
to lipopolysaccharides, and apoptosis. Initial comparisons 
of the changes in expression relative to the reference genes 
showed that the expression of these genes within the IECs 
and mucosal biopsies was dissimilar in both UC and healthy 
tissue. Importantly in the case of 12 of these genes, the direc-
tion of expression was inconsistent between sample types (i.e., 
upregulated in one sample type and downregulated in the 
other). This illustrates how the confounding issues of mixed 
tissue and cell types are likely to mask subtle changes in gene 
expression within low abundance cell types of a given sample. 
The method allowed investigation of genes involved in 
MGL secretion directly in the cells that produce the constitu-
ent mucus. In doing so, an increase in MUC2 production 
by goblet cells and a corresponding decrease in TFF3 was 
identified, reflecting a reduction in both the stabilization and 
protective capacity.44 
The expression of microbial sensing receptors (TLR2 
and 4) was downregulated in epithelial cells from patients 
with active UC, a finding that was masked in the assessments 
of whole mucosal biopsies. A dichotomy in the expression of 
bacterial defensins was also observed, with downregulation 
of defensins in epithelial cells and upregulation in mucosa. 
Downregulation of intestinal DEFb1, the function of which 
is to prevent microbes colonizing the inner sterile MGL,45 
supports the hypothesis of a dysfunctioning MGL in UC. This 
reduced protective capacity of the MGL may afford bacterial 
species or their endotoxins an opportunity to colonize close 
to or within the colonic mucosa, triggering an overt inflam-
matory response.
These results indicate that current studies utilizing muco-
sal biopsies to investigate specific pathways associated with 
epithelial cell responses may be inadvertently omitting vital 
data and has highlighted the need for subfractioning the 
studies. Furthermore, in the case of the colon, studies offer-
ing expression profiles of the LP would be advantageous to 
understand the mechanisms that are occurring underneath 
the disrupted epithelial layer. The current study has utilized 
tissues from individuals with UC to demonstrate the neces-
sity to specifically investigate gene signatures associated 
with isolated IECs. However, the importance of investigating 
IEC-specific signatures is not limited to conditions associated 
with inflammatory bowel disease. Other conditions such as 
graft-versus-host disease, autism, type 1 diabetes, rheumatoid 
arthritis, and multiple sclerosis have all been implicated with 
pathologies associated with gut health.10–15 
Conclusion
The study describes a robust method for the isolation of 
pure populations of IECs to allow for RNA processing and 
subsequent gene expression analysis. Differences in the gene 
expression signatures between IECs and whole mucosal 
biopsies observed in this study demonstrate the importance 
of sample choice when investigating functions or processes 
directly affecting the epithelial layer. 
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